Julian Dennard

Julian Dennard

Director/Board Member at C7 Health Ltd.

Finance
Technology Services
Communications

Profile

Julian A.
Dennard
was the founder of Technology Venture Partners LLP, which was founded in 2013.
He held the title of Partner at the firm.
Mr. Dennard's current job is as a Director at C7 Health Ltd.
He is also a Fund Principal at Mercia Fund Management Ltd., a position he started in 2018.
Mr. Dennard's former jobs include being a Non-Executive Director at Dynmark International Ltd., an Investment Director at SMH Venture Finance Ltd.
from 2011 to 2014, a Director at Symetrica Security Ltd., an Investment Director at YFM Equity Partners LLP, a Director at W2 Global Data Solutions Ltd., a Principal at Bank of England, a Principal at KPMG Corporate Finance (Australia) Pty Ltd., a Principal at Chase Manhattan Bank (London Branch), and a Manager at KPMG Corporate Finance (United Kingdom).
Mr. Dennard obtained his undergraduate degree from the University of Warwick.

Julian Dennard active positions

CompaniesPositionStart
Private Equity Investor 2016-10-31
Director/Board Member -
All active positions of Julian Dennard

Former positions of Julian Dennard

CompaniesPositionEnd
Director/Board Member 2023-08-15
Private Equity Investor 2014-05-26
Corporate Officer/Principal -
Chief Investment Officer -
Corporate Officer/Principal -
See the detail of Julian Dennard's experience

Training of Julian Dennard

University of Warwick Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Julian Dennard's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies12

Communications

Bank of England

Government

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Technology Services

Technology Services

Electronic Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Julian Dennard
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW